Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dieter Habich is active.

Publication


Featured researches published by Dieter Habich.


Tetrahedron Letters | 1987

Synthesis of a new carbapenem with a 6-methyl hydroxyacetate side chain

Dieter Habich; Wolfgang Hartwig

Abstract The synthesis of the 2-(4-pyridinylthio)-carbapen-2-em-3-carboxylic acid 1b , bearing a 6-methyl hydroxyacetate side chain, is described.


Bioorganic & Medicinal Chemistry | 2002

Straightforward Syntheses of Furanomycin Derivatives and their Biological Evaluation

Uli Kazmaier; Saskia Pähler; Rainer Endermann; Dieter Habich; Hein-Peter Kroll; Bernd Riedl

Several types of furanomycin analogues were synthesized and investigated with respect to their antibacterial activity. Two different synthetic pathways were developed, based on aldol reactions/ring closing metathesis and an ester enolate Claisen rearrangement. Only the natural product and its desmethyl derivative showed antibacterial activity, pointing towards a narrow structure-activity relationship.


Tetrahedron Letters | 1983

A short synthesis of (±) 7-oxo-3-oxa-1-azabicyclo[3.2.0] heptane-2-carboxylic acid.

Dieter Habich; Paul Naab; Karl Georg Metzger

Abstract A short 4-step synthesis of the title compound 3 , an inhibitor of β-lactamases, is presented. The essential step utilizes the palladium(O)-catalyzed deprotection of an allyl ester.


Antiviral Chemistry & Chemotherapy | 2000

A novel peptide aldehyde with activity against human cytomegalovirus in two different in vivo models.

Olaf Weber; Jürgen Reefschläger; Helga Rübsamen-Waigmann; Siegfried Raddatz; Matthias Hesseling; Dieter Habich

Novel peptide aldehydes (PAs) were identified as potent inhibitors of human cytomegalovirus (HCMV) in vitro. Although these compounds were highly effective against HCMV, they did not exhibit any activity against murine cytomegalovirus (MCMV). The purpose of this study was to test the antiviral activity of PA 8 as a representative of this novel class of inhibitors against HCMV in vivo. Because of the strict species specificity of HCMV we had to use two artificial animal models. In the first model, HCMV-infected human cells were entrapped into agarose plugs and transplanted into mice. In the second model, SCID mice were transplanted with human tissues that were subsequently infected with a clinical isolate of HCMV. In these two models the antiviral activity of PA 8 was clearly demonstrated, ganciclovir only being slightly superior in its in vivo antiviral activity.


Beilstein Journal of Organic Chemistry | 2012

Synthetic studies towards bottromycin

Stefanie Ackermann; Hans-Georg Lerchen; Dieter Habich; Angelika Ullrich; Uli Kazmaier

Summary Thio-Ugi reactions are described as an excellent synthetic tool for the synthesis of sterically highly hindered endothiopeptides. S-Methylation and subsequent amidine formation can be carried out in an inter- as well as in an intramolecular fashion. The intramolecular approach allows the synthesis of the bottromycin ring system in a straightforward manner.


Synthesis | 1979

PREPARATION OF ARYL- AND HETEROARYLTRIMETHYLSILANES

Dieter Habich; Franz Effenberger


Archive | 1996

Heterobenzocyclopentane oxazolidinones having antibacterial activity

Andreas Stolle; Dieter Habich; Stephan Bartel; Bernd Riedl; Martin Ruppelt; Hanno Wild; Rainer Endermann; Klaus-Dieter Bremm; Hein-Peter Kroll; Harald Labischinski; Klaus Schaller; Hans-Otto Werling


Archive | 1995

5-membered heteroaryl-oxazolidinones

Bernd Riedl; Dieter Habich; Andreas Stolle; Hanno Wild; Rainer Endermann; Klaus Dieter Bremm; Hein-Peter Kroll; Harald Labischinski; Klaus Schaller; Hans-Otto Werling


Archive | 1995

Benzoxazolyl- and benzothiazolyloxazolidinones

Dieter Habich; Bernd Riedl; Martin Ruppelt; Andreas Stolle; Hanno Wild; Rainer Endermann; Klaus Dieter Bremm; Hein-Peter Kroll; Harald Labischinski; Klaus Schaller; Hans-Otto Werling


Archive | 1995

6-membered nitrogen-containing heteroaryl-oxazolidinones

Bernd Riedl; Dieter Habich; Andreas Stolle; Hanno Wild; Rainer Endermann; Klaus Dieter Bremm; Hein-Peter Kroll; Harald Labischinski; Klaus Schaller; Hans-Otto Werling

Collaboration


Dive into the Dieter Habich's collaboration.

Researchain Logo
Decentralizing Knowledge